Not available
Quote | Zogenix Inc. (NASDAQ:ZGNX)
Last: | $26.68 |
---|---|
Change Percent: | 1.6% |
Open: | $26.6 |
Close: | $26.68 |
High: | $26.9 |
Low: | $26.51 |
Volume: | 11,251,720 |
Last Trade Date Time: | 03/04/2022 04:55:43 pm |
News | Zogenix Inc. (NASDAQ:ZGNX)
UCB Completes Acquisition of Zogenix, Inc. - Broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy - Total transaction value of up to approximately US$ 1.9 billion / € 1.7 billion. Th...
Three potential deals come to fruition. Healthcare Trust of America to combine with Healthcare Realty Trust in a stock plus cash deal. Chevron to acquire Renewable Energy Group for $3.15 billion, or $61.50 per share, representing a premium of 40.38%. Cedar Realty Trust enters ...
Message Board Posts | Zogenix Inc. (NASDAQ:ZGNX)
Subject | By | Source | When |
---|---|---|---|
UCB Buys Rare Disease Drugmaker Zogenix For Up | TRUISM | investorshub | 01/19/2022 5:26:35 PM |
whytestocks: $ZGNX News Article - ZGNX Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Acqui | whytestocks | investorshangout | 01/19/2022 3:47:05 PM |
whytestocks: $ZGNX News Article - Zogenix Announces U.S. FDA Acceptance for Priority Review of Suppl | whytestocks | investorshangout | 12/01/2021 3:30:55 PM |
whytestocks: $ZGNX News Article - Zogenix Receives Positive CHMP Opinion for FINTEPLA (Fenfluramine) | whytestocks | investorshangout | 10/16/2020 4:14:50 PM |
FDA Approves FINTEPLA (fenfluramine) for the Treatment of | I-Glow | investorshub | 08/03/2020 1:35:13 AM |
News, Short Squeeze, Breakout and More Instantly...
UCB Completes Acquisition of Zogenix, Inc. - Broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy - Total transaction value of up to approximately US$ 1.9 billion / € 1.7 billion. Th...
Zogenix Inc. (NASDAQ:ZGNX) traded today at a new 52-week high of $26.66. Approximately 1.2 million shares have changed hands today, as compared to an average 30-day volume of 3.7 million shares. Zogenix Inc. (NASDAQ:ZGNX) defies analysts with a current price ($26.57) 0.4% above its avera...
Two podium and one poster presentation share important new findings on FINTEPLA’s safety profile and its impact on non-seizure related benefits for LGS patients LGS is a debilitating childhood-onset developmental and epileptic encephalopathy estimated to affect approx...